FIELD: medicine.
SUBSTANCE: invention relates to medicine. Method for stimulating angiogenesis is proposed in which monocular blood cells of the umbilical cord transduced with the Ad VEGF + Ad Ang combination are introduced into the ischemia region.
EFFECT: invention provides increase in the number and size of endothelial cells and can be useful in the treatment of various types of ischemic lesions.
1 cl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR REGULATING NERVOUS FIBERS OF BLOOD VESSELS | 2018 |
|
RU2682160C2 |
| AGENT FOR REPRESSION OF DEATH OF NEURONS IN ISCHEMIC STROKE OF BRAIN AND METHOD OF CELL-MEDIATED GENE THERAPY FOR ISCHEMIC STROKE OF BRAIN BY REPRESSION OF DEATH OF NEURONS IN ISCHEMIC STROKE OF BRAIN | 2017 |
|
RU2676701C1 |
| METHOD FOR TREATING TRAUMATIC SPINAL CORD INJURY | 2021 |
|
RU2758760C1 |
| METHOD FOR SIMULATING ANGIOGENESIS, TREATING NEUROGENERATIVE DISEASES AND REGENERATING SKELETAL MUSCLE USING PLASMID CONSTRUCTS WITH GENES FOR ANGIOGENIC AND NEUROTROPHIC FACTORS | 2020 |
|
RU2805082C2 |
| METHOD FOR PREVENTIVE GENE THERAPY FOR SUPPRESSING NEURON DEATH IN ISCHEMIC BRAIN STROKE | 2020 |
|
RU2748940C2 |
| METHOD FOR STIMULATING NEUROGENERATION BY GENETIC MAKE-UPS | 2011 |
|
RU2459630C1 |
| NON-INFECTIOUS FOR HUMAN ADENOVIRUS AS VECTOR FOR SUBSTITUTION GENETIC THERAPY OF ANGIOGENESIS DISORDER PROVIDING EFFECTIVE SYNTHESIS OF HUMAN ANGIOGENIN IN MAMMALIAN TRANSFECTED CELLS, METHOD FOR ANGIOGENESIS INDUCTION, METHOD FOR TREATMENT OF ISCHEMIC DISEASE, COMPOSITION FOR INDUCTION OF ANGIOGENESIS AND TREATMENT OF ISCHEMIC DISEASE | 2005 |
|
RU2321631C2 |
| METHOD FOR PREPARING A CELL-MEDIATED GENE THERAPY AGENT AND A CELL-MEDIATED GENE THERAPY AGENT | 2019 |
|
RU2716013C2 |
| METHOD FOR STIMULATING SPINAL CORD REGENERATION WITH GENETICALLY MODIFIED HUMAN UMBILICAL CORD BLOOD CELLS | 2013 |
|
RU2521225C2 |
| CELL-BASED THERAPY OF ISCHEMIC TISSUE | 2009 |
|
RU2535966C2 |
